J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
Dipak Kotecha,Dipak Kotecha,Jane Holmes,Henry Krum,Douglas G. Altman,Luis Manzano,John G.F. Cleland,John G.F. Cleland,Gregory Y.H. Lip,Gregory Y.H. Lip,Andrew J.S. Coats,Andrew J.S. Coats,Bert Andersson,Paulus Kirchhof,Paulus Kirchhof,Thomas G. von Lueder,Thomas G. von Lueder,Hans Wedel,Giuseppe M.C. Rosano,Marcelo C. Shibata,Alan S. Rigby,Marcus Flather +21 more
TL;DR: Based on the findings, β blockers should not be used preferentially over other rate-control medications and not regarded as standard therapy to improve prognosis in patients with concomitant heart failure and atrial fibrillation.
Journal ArticleDOI
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
John G.F. Cleland,William T. Abraham,Cecilia Linde,Michael R. Gold,James B. Young,J. Claude Daubert,Lou Sherfesee,George A. Wells,Anthony S.L. Tang +8 more
TL;DR: QRS duration is a powerful predictor of the effects of CRT on morbidity and mortality in patients with symptomatic HF and left ventricular systolic dysfunction who are in sinus rhythm.
Journal ArticleDOI
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure : implant and follow-up recommendations and management
Jean-Claude Daubert,Leslie A. Saxon,Philip B. Adamson,Angelo Auricchio,Ronald D. Berger,John F. Beshai,Ole Breithard,Michele Brignole,John G.F. Cleland,David B. Delurgio,Kenneth Dickstein,Derek V. Exner,Michael S. Gold,Richard A. Grimm,David L. Hayes,Carsten W. Israel,Christophe Leclercq,Cecilia Linde,JoAnn Lindenfeld,Béla Merkely,Lluís Mont,Francis Murgatroyd,Frits W. Prinzen,Samir Saba,Jerold S. Shinbane,Jagmeet P. Singh,Anthony S.L. Tang,Panos E. Vardas,Bruce L. Wilkoff,José Luis Zamorano +29 more
TL;DR: 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure : implant and follow-up recommendations and management.
Journal ArticleDOI
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.
John G.F. Cleland,Iain N Findlay,Syed M. Jafri,George C. Sutton,Rodney H. Falk,Christopher J. Bulpitt,C. Prentice,Ian Ford,Adele Trainer,Philip A. Poole-Wilson +9 more
TL;DR: The Warfarin/Aspirin Study in Heart failure provides no evidence that aspirin is effective or safe in patients with heart failure, and the benefits of warfarin for patients withHeart failure in sinus rhythm have not been established.
Journal ArticleDOI
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
Christian Mueller,Kenneth McDonald,Rudolf A. de Boer,Alan S. Maisel,John G.F. Cleland,Nikola Kozhuharov,Andrew J.S. Coats,Andrew J.S. Coats,Marco Metra,Alexandre Mebazaa,Frank Ruschitzka,Mitja Lainscak,Gerasimos Filippatos,Gerasimos Filippatos,Petar M. Seferovic,Wouter C. Meijers,Antoni Bayes-Genis,Thomas Mueller,Mark Richards,Mark Richards,James L. Januzzi +20 more
TL;DR: Screening with NPs for the early detection of relevant cardiac disease including left ventricular systolic dysfunction in patients with cardiovascular risk factors may help to identify patients at increased risk, therefore allowing targeted preventive measures to prevent HF.